DEERFIELD, Ill., Nov. 16 /PRNewswire-FirstCall/ -- Baxter International Inc. announced today the appointment of Cheryl L. White as vice president Quality, effective immediately. She will report to Baxter Chairman and CEO Robert L. Parkinson, Jr., and will serve in this capacity while the company conducts a national search for a corporate vice president of Quality. White has agreed to be a candidate for that position as well.
Lawrence T. Gibbons, who joined Baxter in 2003 as corporate vice president Quality, has left the company to pursue other interests.
“Improving quality in order to better serve patients is Baxter’s central mission,” said Parkinson. “We’ve made significant changes to our senior management team to help reinforce Baxter’s position of leadership. This appointment further strengthens that team. Product innovation, quality, and reliability have been hallmarks of Baxter throughout our long history, and we are taking the necessary steps to make sure we maintain and enhance that focus.”
In her new role, White will be responsible for leading the quality function. She has been with Baxter for eight years, most recently as vice president, BioScience Quality Management in Westlake, Calif. She has held senior positions within the BioScience business with direct supervision over global manufacturing facilities and product development for biopharmaceutical products, biosurgery and vaccines. Prior to joining the company, she managed quality control and quality assurance activities for Hybritech, at the time a division of Eli Lilly and Beckman Instruments. In addition, she spent nine years in academic research in the University of California system.
White earned her MBA from the University of California, Irvine, and her BA in Biology from the University of California, San Diego.
“Cheryl has significant experience overseeing quality activities within the BioScience business,” said Parkinson. “In this role she has very successfully guided a key part of our business that requires the highest levels of quality control and regulatory compliance. She played a vital leadership position in the successful validation, staffing and licensure of the ADVATE manufacturing facility in Neuchatel, Switzerland.”
Baxter International Inc., through its subsidiaries, assists health-care professionals and their patients with treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease, and trauma. The company applies its expertise in medical devices, pharmaceuticals, and biotechnology to make a meaningful difference in patients’ lives.
Baxter International Inc.
CONTACT: Media, Cindy Resman, +1-847-948-2815, or Investors, Mary KayLadone, +1-847-948-3371, both of Baxter International Inc.
Web site: http://www.baxter.com/
